The Drugs for Neglected Diseases Initiative is a new, public- sector organization dedicated to drug discovery
No takes yet. Share an insight, caveat, or question.
Bernard Pécoul (2004) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: